Status:
COMPLETED
Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding
Lead Sponsor:
Hartford Hospital
Conditions:
Hoarding Disorder
Attentional Impairment
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compul...
Detailed Description
The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compul...
Eligibility Criteria
Inclusion
- be over 18 years of age,
- have a current primary diagnosis of hoarding disorder
- have no untreated and/or unstable concurrent psychiatric diagnoses
- have a score on the ADHDSS that is one standard deviation or more above the mean
- have an Attentional Composite score on the computerized battery of neuropsychological tests (Doniger, 2010) that is one standard deviation or more below the mean
- be stable on all psychotropic medications during and up to four weeks preceding enrollment in the study
Exclusion
- currently taking any cognitive enhancers or stimulants
- people with a history of Multiple Sclerosis, Traumatic Brain Injury, loss of consciousness lasting more than 5 minutes, seizures, dementia, or other organic brain-related disorders
- current Alcohol or Substance Abuse and/or a history of Alcohol or Substance Dependence
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01451697
Start Date
July 1 2011
End Date
October 1 2012
Last Update
May 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anxiety Disorders Center, Institute of Living/Hartford
Hartford, Connecticut, United States, 06106